临床药师参与1例肺部重症感染患者治疗方案的调整  

Clinical Pharmacists Participating in the Adjustment of Treatment Programs for 1 Case of Severe Pulmonary Infection

作　　者：胡晓蕾[1] 詹世鹏[1] 王渝[1] 何菊英[1] 

机构地区：[1]第三军医大学西南医院药学部,重庆400038

出　　处：《中国药房》2013年第26期2491-2494,共4页China Pharmacy

摘　　要：目的:探讨临床药师在重症感染患者救治中的作用。方法:临床药师参与神经外科1例颅脑术后并发肺部重症感染患者的会诊工作,结合本院肺炎克雷伯菌、鲍曼不动杆菌、大肠埃希菌的细菌耐药情况和药敏结果,为患者制订最佳的个体化治疗方案,先后使用了头孢哌酮/舒巴坦、替考拉宁、阿米卡星抗感染治疗。结果:患者肺部感染情况逐渐好转,得到了有效的控制。结论:临床药师利用自己的专业知识参与到重症感染患者的临床治疗过程,不但可提高临床治疗水平使患者得到最大的收益,而且可以使临床药师逐步得到临床医师的认可。OBJECTIVE： To investigate the role of clinical pharmacist in the treatment of patients with severe infections diseas-es. METHODS： Clinical pharmacist involved in the consultations of a neurosurgical patient with severe pulmonary infection after. craniocerebral surgery, and developed the best individualized treatment plan for the patient, combining with drug resistance and sus- ceptibility results of Klebsiella pneumoniae, Acinetobacter baumannii and Escherichia coli. Cefoperazone/sulbactam, teicoplanin and amikacin were used for anti-infective treatment, respectively. RESULTS： The pulmonary infection of patient was improved gradually and controlled effectively. CONCLUSIONS： Clinical pharmacists use their professional knowledge to participate in the clinical course of treatment, so that severe infection patient can get the maximum benefit. It will not only enhance the level of clini-cal treatment, and also make clinical pharmacists gradually be recognized by clinicians.

关 键 词：临床药师 肺炎克雷伯菌 鲍曼不动杆菌 大肠埃希菌 治疗方案 

分 类 号：R978.1[医药卫生—药品] R969.3[医药卫生—药学]